332 related articles for article (PubMed ID: 27358242)
1. Reframing the association and significance of co-morbidities in heart failure.
Triposkiadis F; Giamouzis G; Parissis J; Starling RC; Boudoulas H; Skoularigis J; Butler J; Filippatos G
Eur J Heart Fail; 2016 Jul; 18(7):744-58. PubMed ID: 27358242
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
3. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.
van Deursen VM; Urso R; Laroche C; Damman K; Dahlström U; Tavazzi L; Maggioni AP; Voors AA
Eur J Heart Fail; 2014 Jan; 16(1):103-11. PubMed ID: 24453099
[TBL] [Abstract][Full Text] [Related]
4. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.
Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Löfman I; Ennezat PV; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
Eur J Heart Fail; 2014 Sep; 16(9):992-1001. PubMed ID: 25046483
[TBL] [Abstract][Full Text] [Related]
5. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
Mentz RJ; Kelly JP; von Lueder TG; Voors AA; Lam CS; Cowie MR; Kjeldsen K; Jankowska EA; Atar D; Butler J; Fiuzat M; Zannad F; Pitt B; O'Connor CM
J Am Coll Cardiol; 2014 Dec; 64(21):2281-93. PubMed ID: 25456761
[TBL] [Abstract][Full Text] [Related]
6. Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
Yang M; Kondo T; Adamson C; Butt JH; Abraham WT; Desai AS; Jering KS; Køber L; Kosiborod MN; Packer M; Rouleau JL; Solomon SD; Vaduganathan M; Zile MR; Jhund PS; McMurray JJV
Eur J Heart Fail; 2023 Sep; 25(9):1606-1618. PubMed ID: 37401511
[TBL] [Abstract][Full Text] [Related]
7. The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
J Cardiol; 2018 Jul; 72(1):26-32. PubMed ID: 29358024
[TBL] [Abstract][Full Text] [Related]
8. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities in Heart Failure.
van der Wal HH; van Deursen VM; van der Meer P; Voors AA
Handb Exp Pharmacol; 2017; 243():35-66. PubMed ID: 28382470
[TBL] [Abstract][Full Text] [Related]
10. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
Meifang W; Ying W; Wen C; Kaizu X; Meiyan S; Liming L
Heart Fail Rev; 2024 Mar; 29(2):305-320. PubMed ID: 37561223
[TBL] [Abstract][Full Text] [Related]
11. Heart failure with preserved ejection fraction in Asia.
Tromp J; Teng TH; Tay WT; Hung CL; Narasimhan C; Shimizu W; Park SW; Liew HB; Ngarmukos T; Reyes EB; Siswanto BB; Yu CM; Zhang S; Yap J; MacDonald M; Ling LH; Leineweber K; Richards AM; Zile MR; Anand IS; Lam CSP;
Eur J Heart Fail; 2019 Jan; 21(1):23-36. PubMed ID: 30113120
[TBL] [Abstract][Full Text] [Related]
12. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.
Chamberlain AM; Boyd CM; Manemann SM; Dunlay SM; Gerber Y; Killian JM; Weston SA; Roger VL
Am J Med; 2020 Jun; 133(6):e237-e248. PubMed ID: 31747542
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities, Sociodemographic Factors, and Hospitalizations in Outpatients With Heart Failure and Preserved Ejection Fraction.
Georgiopoulou VV; Velayati A; Burkman G; Li S; Farooq K; Samman-Tahhan A; Papadimitriou L; Butler J; Kalogeropoulos AP
Am J Cardiol; 2018 May; 121(10):1207-1213. PubMed ID: 29525061
[TBL] [Abstract][Full Text] [Related]
15. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study).
Magaña-Serrano JA; Almahmeed W; Gomez E; Al-Shamiri M; Adgar D; Sosner P; Herpin D;
Am J Cardiol; 2011 Nov; 108(9):1289-96. PubMed ID: 22000627
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.
Sugumar H; Nanayakkara S; Prabhu S; Voskoboinik A; Kaye DM; Ling LH; Kistler PM
Cardiol Clin; 2019 May; 37(2):131-138. PubMed ID: 30926014
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities and differential diagnosis in heart failure with preserved ejection fraction.
Campbell RT; McMurray JJ
Heart Fail Clin; 2014 Jul; 10(3):481-501. PubMed ID: 24975911
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE).
Sulaiman K; Panduranga P; Al-Zakwani I; Alsheikh-Ali AA; AlHabib KF; Al-Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
Eur J Heart Fail; 2015 Apr; 17(4):374-84. PubMed ID: 25739882
[TBL] [Abstract][Full Text] [Related]
20. Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
Kupsky DF; Ahmed AM; Sakr S; Qureshi WT; Brawner CA; Blaha MJ; Ehrman JK; Keteyian SJ; Al-Mallah MH
Am Heart J; 2017 Mar; 185():35-42. PubMed ID: 28267473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
